[LGND] YoY Quarter Result on 31-Dec-2015 [#Q4]

Stock
[LGND] Ligand Pharmaceuticals Incorporated
Announcement Date
26-Feb-2016
Financial Year
2015
Quarter
31-Dec-2015 [#Q4]
Profit Trend
QoQ- -96.82%
YoY- -10.12%
Quarter Report
LGND's Result
LGND's Financial Summary
View:
Show?
Quarter Result
31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 CAGR
Revenue 59,590 50,464 38,185 21,192 22,998 14,737 13,635 27.85%
PBT -56,789 30,665 7,230 5,826 7,012 2,008 950 -
Tax -14,307 37,675 10,355 -515 279 139 -1,636 43.51%
NP -42,482 -7,010 -3,125 6,341 7,055 1,869 1,063 -
Tax Rate - -122.86% -143.22% 8.84% -3.98% -6.92% 172.21% -
Total Cost 102,072 57,474 41,310 14,851 15,943 12,868 12,572 41.74%
Ratio Analysis
31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 CAGR
NP Margin -71.29 -13.89 -8.18 29.92 30.68 12.68 7.80 -
Per Share
31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 CAGR
EPS -2.02 -0.34 -0.15 0.32 0.35 0.09 0.05 -
EPS Diluted -2.02 -0.33 -0.15 0.29 0.34 0.09 0.05 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.